Thrombospondins and premature coronary artery disease: Time to go beyond genotype-phenotype association studies

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 1, 2003, Pages 6-7

  Hamsten, Anders ^a   Eriksson, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN; GLYCOPROTEIN; HYALURONIC ACID; PROTEOGLYCAN; SCLEROPROTEIN; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; THROMBOSPONDIN 5; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALLELE; AMINO ACID SUBSTITUTION; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; EDITORIAL; EXTRACELLULAR MATRIX; GENE CONTROL; GENETIC VARIABILITY; GENOME; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEART INFARCTION; HOMOZYGOSITY; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS; THROMBOSIS;

3' UNTRANSLATED REGIONS; CORONARY ARTERIOSCLEROSIS; EXTRACELLULAR MATRIX PROTEINS; GENOTYPE; HUMANS; MUTATION; PHENOTYPE; THROMBOSPONDIN 1; THROMBOSPONDINS;

EID: 0037233945     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000051871.32874.6A     Document Type: Editorial

References (14)

1. Wight TN, Raugi GJ, Mumby SM, Bornstein P. Light microscopic immunolocalization of thrombospondin secretion in human tissues. J Histochem Cytochem. 1985;33:295-302.
2. Riessen R, Kearney M, Lawler J, Isner JM. Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. Am Heart J. 1998;135:357-364.
3. Riessen R, Fenchel M, Chen H, Axel DI, Karsch KR, Lawler J. Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:47-54.
4. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol. 1995;130:503-506.
5. Narouz-Ott L, Maurer P, Nitsche DP, Smyth N, Paulsson M. Thrombospondin-4 binds specifically to both collagenous and noncollagenous extracellular matrix proteins via its C-terminal domains. J Biol Chem. 2000;275:37110-37117.
6. Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, Freedman M, Metivier J, Cannata R, O'Donnell CJ, Kottke-Marchant K, Murugesan G, Plow EF, Stenina O, Daley GQ, for the GeneQuest investigators and collaborators. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation. 2001;104:2641-2644.
7. Boekholdt SM, Trip MD, Peters RJG, Engelen M, Boer JMA, Feskens EJM, Zwinderman AH, Kastelein JJP, Reitsma PH. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2002;22:2092.
8. Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell. 2000;11:3353-3364.
9. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis an increased vascular density, and a bleeding diathesis. J Cell Biol. 1998;140:419-430.
10. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306-309.
11. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet. 2001;2:91-99.
12. Hegele RA. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol. 2002;22:1058-1061.
13. Gambaro G, Anglani F, d'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 2000;355:308-311.
14. Vieland VJ. The replication requirement. Nat Genet. 2001;29:244-245.